Production (Stage)
Kronos Bio, Inc.
KRON
$0.872
$0.00210.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.15% | 56.62% | 146.48% | 172.64% | 521.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.15% | 56.62% | 146.48% | 172.64% | 521.38% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 21.15% | 56.62% | 146.48% | 172.64% | 521.38% |
| SG&A Expenses | -36.24% | -34.56% | -26.08% | -18.59% | -10.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.24% | -40.66% | -32.02% | -18.38% | -11.47% |
| Operating Income | 53.11% | 45.88% | 37.73% | 23.09% | 16.50% |
| Income Before Tax | 44.60% | 23.60% | 28.16% | 14.30% | 5.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.60% | 23.60% | 28.16% | 14.30% | 5.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.60% | 23.60% | 28.16% | 14.30% | 5.51% |
| EBIT | 53.11% | 45.88% | 37.73% | 23.09% | 16.50% |
| EBITDA | 53.59% | 46.36% | 38.05% | 23.19% | 16.61% |
| EPS Basic | 46.44% | 26.48% | 30.68% | 17.29% | 8.48% |
| Normalized Basic EPS | 56.25% | 49.46% | 41.66% | 27.78% | 22.21% |
| EPS Diluted | 46.44% | 26.48% | 30.68% | 17.29% | 8.48% |
| Normalized Diluted EPS | 56.25% | 49.46% | 41.66% | 27.78% | 22.21% |
| Average Basic Shares Outstanding | 3.53% | 4.03% | 3.92% | 3.80% | 3.20% |
| Average Diluted Shares Outstanding | 3.53% | 4.03% | 3.92% | 3.80% | 3.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |